{"id":5056,"date":"2021-10-01T15:10:02","date_gmt":"2021-10-01T12:10:02","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=5056"},"modified":"2021-10-01T16:21:29","modified_gmt":"2021-10-01T13:21:29","slug":"yeni-antiviral-ilac-covid-19-tedavisinde-son-derece-etkili-bulundu","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/yeni-antiviral-ilac-covid-19-tedavisinde-son-derece-etkili-bulundu\/","title":{"rendered":"Yeni Antiviral \u0130la\u00e7 COVID-19 Tedavisinde Son Derece Etkili Bulundu"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\" wp-image-95472 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2020\/09\/USA.Today_.png\" alt=\"\" width=\"71\" height=\"29\" \/><strong>Cuma g\u00fcn\u00fc yay\u0131mlanan ve virusun yak\u0131nda bir hapla tedavi edilebilece\u011fini vadeden bir ara\u015ft\u0131rmaya g\u00f6re, deneysel bir ila\u00e7, insanlar\u0131n hastaneye yatmas\u0131na neden olacak ciddi COVID-19 infeksiyonlar\u0131n\u0131n yar\u0131s\u0131n\u0131 \u00f6nledi.<\/strong><\/p>\n<p>Merck &amp; Co. ve Miami&#8217;deki Ridgeback Biotherapy taraf\u0131ndan \u00fcretilen antiviral ila\u00e7 molnupiravir, COVID-19 te\u015fhisi konulduktan sonraki be\u015f g\u00fcn i\u00e7inde 385 ki\u015fiye verildi. Testi pozitif \u00e7\u0131kan 377 g\u00f6n\u00fcll\u00fcye ise plasebo verildi.<\/p>\n<p>T\u00fcm kat\u0131l\u0131mc\u0131lar\u0131n \u015fiddetli COVID-19 i\u00e7in en az bir risk fakt\u00f6r\u00fc vard\u0131. \u015eirketler, kat\u0131l\u0131mc\u0131lar\u0131n 60 ya\u015f\u0131n \u00fczerinde olduklar\u0131n\u0131 ya da diyabet, obezite veya kalp hastal\u0131\u011f\u0131na sahip olduklar\u0131n\u0131 bildirdiler.<\/p>\n<p>Aslen Atlanta&#8217;daki Emory \u00dcniversitesi&#8217;ndeki ara\u015ft\u0131rmac\u0131lar taraf\u0131ndan geli\u015ftirilen molnupiravir, be\u015f g\u00fcn boyunca g\u00fcnde iki kez al\u0131nan d\u00f6rt hap olarak verildi.<\/p>\n<p>Bir ay s\u00fcren deneme s\u0131ras\u0131nda molnupiravir alan kat\u0131l\u0131mc\u0131lar\u0131n 28&#8217;i (%7.3) hastaneye kald\u0131r\u0131ld\u0131. Plasebo grubunda ise 53 ki\u015fi (%14) hastaneye kald\u0131r\u0131ld\u0131 ve bunlardan sekizi ya\u015fam\u0131n\u0131 yitirdi.<\/p>\n<p>\u00c7al\u0131\u015fmaya 750 kat\u0131l\u0131mc\u0131n\u0131n daha kat\u0131lmas\u0131 gerekiyordu, ancak ba\u011f\u0131ms\u0131z bir izleme kurulu, ilac\u0131n \u00e7ok etkili oldu\u011funa ve herhangi birine plasebo vermeye devam etmenin etik olmayaca\u011f\u0131na karar verdi.<\/p>\n<p><strong><a href=\"https:\/\/www.usatoday.com\/story\/news\/2021\/10\/01\/new-antiviral-drug-molnupiravir-prevented-half-severe-covid-19-infections-study-found\/5938807001\/\">Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/a><\/strong><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cuma g\u00fcn\u00fc yay\u0131mlanan ve virusun yak\u0131nda bir hapla tedavi edilebilece\u011fini vadeden bir ara\u015ft\u0131rmaya g\u00f6re, deneysel bir ila\u00e7, insanlar\u0131n hastaneye yatmas\u0131na neden olacak ciddi COVID-19 infeksiyonlar\u0131n\u0131n yar\u0131s\u0131n\u0131 \u00f6nledi. Merck &amp; Co. ve Miami&#8217;deki Ridgeback Biotherapy taraf\u0131ndan \u00fcretilen antiviral ila\u00e7 molnupiravir, COVID-19 te\u015fhisi konulduktan sonraki be\u015f g\u00fcn i\u00e7inde 385 ki\u015fiye verildi. Testi pozitif \u00e7\u0131kan 377 g\u00f6n\u00fcll\u00fcye ise plasebo verildi. T\u00fcm kat\u0131l\u0131mc\u0131lar\u0131n \u015fiddetli COVID-19 i\u00e7in en az bir risk fakt\u00f6r\u00fc vard\u0131. \u015eirketler, kat\u0131l\u0131mc\u0131lar\u0131n 60 ya\u015f\u0131n \u00fczerinde olduklar\u0131n\u0131 ya da diyabet, obezite veya kalp hastal\u0131\u011f\u0131na sahip olduklar\u0131n\u0131 bildirdiler. Aslen Atlanta&#8217;daki Emory \u00dcniversitesi&#8217;ndeki ara\u015ft\u0131rmac\u0131lar taraf\u0131ndan geli\u015ftirilen molnupiravir, be\u015f g\u00fcn boyunca g\u00fcnde iki kez al\u0131nan d\u00f6rt [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5057,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5056"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=5056"}],"version-history":[{"count":4,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5056\/revisions"}],"predecessor-version":[{"id":5061,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5056\/revisions\/5061"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/5057"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=5056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=5056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=5056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}